Form 4: Arteris CEO Sells Shares Under 10b5-1 Plan

Arteris, Inc. President and CEO, Janac K Charles, sold 2,116 shares of common stock for $17.7901 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Janac K Charles, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported a sale of common stock.
• The transaction involved the disposition of 2,116 shares of Common Stock on January 13, 2026.
• The shares were sold at a weighted average price of $17.7901, with individual sales ranging from $17.7500 to $17.8100.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Charles on March 5, 2025.
• Following the transaction, Mr. Charles directly owns 139,487 shares of Common Stock.
• He also indirectly beneficially owns 9,416,955 shares through Bayview Legacy, LLC, where he is the manager, and 56,252 shares through the Charles and Lydia Janac Trust, where he serves as trustee.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale executed under a pre-established 10b5-1 trading plan, which typically minimizes any strong positive or negative sentiment implications as it is not indicative of new information or a change in management's outlook.

Positives

• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-scheduled sale rather than a reaction to immediate market conditions.

Negatives

• An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the pre-planned nature of the sale under a 10b5-1 plan mitigates concerns about its implications.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.

Key Dates

Keywords

Arteris Inc., AIP, Form 4, insider trading, 10b5-1 plan, stock sale, CEO, director, beneficial ownership, common stock